BCL2 and central nervous system cancer: Functional analysis in human gliomas suggested that HOXD9 deletion induced apoptosis via downregulation of anti-apoptotic factor B-cell lymphoma-2 (BCL-2) and upregulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) [8].